Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
1.620
+0.110 (7.28%)
At close: Jan 2, 2026, 4:00 PM EST
1.620
0.00 (0.00%)
After-hours: Jan 2, 2026, 5:34 PM EST
Eledon Pharmaceuticals Market Cap
Eledon Pharmaceuticals has a market cap or net worth of $121.74 million as of January 2, 2026. Its market cap has decreased by -54.41% in one year.
Market Cap
121.74M
Enterprise Value
21.55M
1-Year Change
-54.41%
Ranking
Category
Stock Price
$1.62
Market Cap Chart
Since May 11, 2017, Eledon Pharmaceuticals's market cap has increased from $44.66M to $121.74M, an increase of 172.60%. That is a compound annual growth rate of 12.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 121.74M | 7.28% |
| Dec 31, 2025 | 113.47M | -53.90% |
| Dec 31, 2024 | 246.13M | 465.07% |
| Dec 29, 2023 | 43.56M | 38.87% |
| Dec 30, 2022 | 31.37M | -50.29% |
| Dec 31, 2021 | 63.09M | -72.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |